Oragenics
(NYSEMKT) OGEN
Oragenics Financials at a Glance
Market Cap
$2.44M
Revenue (TTM)
$0.00
Net Income (TTM)
$9.84M
EPS (TTM)
$-9.26
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$0.59
Volume
568
Open
$0.59
Price
$0.59
Volume
568
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.61
52-Week Range
$0.50 - $9.60
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$0.59
Volume
568
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.61
52-Week Range
$0.50 - $9.60
OGEN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oragenics
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Janet Huffman
Website
www.oragenics.comHeadquarters
Tampa, FL 33634, US
OGEN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-244%
Return on Capital
-1%
Return on Assets
-98%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.44M
Shares Outstanding
4.34M
Volume
568
Short Interest
0.00%
Avg. Volume
529.23K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.36M
EBITDA
$9.36M
Operating Cash Flow
$9.25B
Capital Expenditure
$3.00
Free Cash Flow
$9.25B
Cash & ST Invst.
$8.40M
Total Debt
$227.35M
Oragenics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.44M
N/A
Market Cap/Employee
$812.70K
N/A
Employees
3
N/A
Net Income
$2.29M
+31.7%
EBITDA
$2.50M
+25.2%
Quarterly Fundamentals
Net Cash
$218.95M
-40924.8%
Accounts Receivable
$53.08M
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$227.35M
+69102.0%
Return on Assets
-97.76%
N/A
Return on Invested Capital
-1.13%
N/A
Free Cash Flow
$2.84M
-40.5%
Operating Cash Flow
$2.84M
-40.5%